AVIENCE BIOMEDICALS LTD (AVIENCE-SM) Share Price Rises 9.89% Today
- September 22, 2026
- Posted by: Harsh Piplani
- Category: News
AVIENCE BIOMEDICALS LTD Share Price is in focus after the stock rose 9.89% to Rs 359 from Rs 326.7, adding Rs 32.3 in a single session. The company’s market capitalisation stands at Rs 187.81 cr, placing the move in a clear market-cap context for today’s AVIENCE BIOMEDICALS LTD Share Price Today update. The supplied data confirms the price event, but it does not establish a company-specific catalyst. That makes this a useful AVIENCE BIOMEDICALS LTD Stock News note for readers tracking price action, valuation and sector positioning on Univest.
The session opened at Rs 330.55, traded between Rs 321 and Rs 359.35, and ended near the day’s high. Turnover stood at Rs 3.58 cr, which helps quantify traded value without implying any behavioural explanation. For investors scanning AVIENCE BIOMEDICALS LTD Share News and AVIENCE BIOMEDICALS LTD Share Price Live, the key question is not only why the stock is rising today, but how the move fits with its fundamentals, healthcare industry peers and current valuation on Univest.
AVIENCE BIOMEDICALS LTD Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 359 |
| Previous Close | Rs 326.7 |
| Today's Move | Rs 32.3 (+9.89%) |
| Open | Rs 330.55 |
| High | Rs 359.35 |
| Low | Rs 321 |
| Turnover | Rs 3.58 crore |
| Market Capitalisation | Rs 187.81 crore |
| Market Cap Category | Micro Cap |
AVIENCE BIOMEDICALS LTD (AVIENCE-SM) rose to Rs 359 from the previous close of Rs 326.7, a move of Rs 32.3 or 9.89%. The stock opened at Rs 330.55, reached a high of Rs 359.35, recorded a low of Rs 321.
The stock gained 9.89% today, rising Rs 32.3 from the previous close of Rs 326.7 to Rs 359. It opened at Rs 330.55, touched a low of Rs 321 and a high of Rs 359.35, and finished close to the session peak. Turnover of Rs 3.58 cr provides the traded-value context for the move. This is the core AVIENCE BIOMEDICALS LTD Share Price Today development and the main reason the name is appearing in Stocks in News and Top Gainers Today style screens on the Indian stock market.
From a pure price-action perspective, the day shows a strong intraday climb relative to the previous close, but the supplied data does not establish any specific trigger. Readers tracking AVIENCE BIOMEDICALS LTD Share Price on Univest can therefore focus on the verified numbers first: current price, percentage rise, day range, turnover and market capitalisation. That is the cleanest way to interpret AVIENCE BIOMEDICALS LTD Stock Performance on a day when the stock is rising today.
AVIENCE BIOMEDICALS LTD (AVIENCE-SM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 187.81 crore |
| P/E Ratio | 20.47x |
| P/B Ratio | 7.4x |
| ROE | 49.9% |
| ROCE | 34.16% |
| EPS | Rs 15.96 |
| Book Value Per Share | Rs 44.18 |
| Dividend Yield | 0% |
AVIENCE BIOMEDICALS LTD (AVIENCE-SM) fundamental metrics show P/E 20.47x, P/B 7.4x, ROE 49.9%, ROCE 34.16%. These figures provide context only and are not a buy or sell signal.
AVIENCE BIOMEDICALS LTD has a market capitalisation of Rs 187.81 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 20.47x, P/B at 7.4x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 49.9% and ROCE of 34.16%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 15.96, book value per share of Rs 44.18, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 34.69x, median ROE of 15.01%, median ROCE of 16.41%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Medical Equipment/Supplies/Accessories |
| Benchmark Scope | same industry |
| Company P/E Ratio | 20.47x |
| Benchmark Median P/E | 34.69x |
| Benchmark Average P/E | 90.33x |
| Benchmark P/E Range | 8.06x to 1,027.7x |
| Company P/B Ratio | 7.4x |
| Benchmark Median P/B | 3.81x |
| Company ROE | 49.9% |
| Benchmark Median ROE | 15.01% |
| Company ROCE | 34.16% |
| Benchmark Median ROCE | 16.41% |
| Company Market Capitalisation | Rs 187.81 crore |
| Benchmark Median Market Cap | Rs 183.31 crore |
AVIENCE BIOMEDICALS LTD (AVIENCE-SM) is classified under sector: Healthcare and industry: Medical Equipment/Supplies/Accessories.
AVIENCE BIOMEDICALS LTD (AVIENCE-SM) has a P/E ratio of 20.47x, which is below the benchmark median of 34.69x, a difference of -40.99%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
AVIENCE BIOMEDICALS LTD (AVIENCE-SM) has a ROE of 49.9%, which is above the benchmark median of 15.01%, a difference of +232.45%. AVIENCE BIOMEDICALS LTD (AVIENCE-SM) has a ROCE of 34.16%, which is above the benchmark median of 16.41%, a difference of +108.17%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| LENSKART SOLUTIONS LTD | LENSKART | 1,22,899.37 | 181.48 | 13.3 | 6.85 | 12.55 |
| Poly Medicure Ltd. | POLYMED | 17,512.73 | 54.78 | 5.42 | 10.94 | 14.05 |
| Q-LINE BIOTECH LIMITED | QLINE | 1,625.86 | 29.23 | 6.43 | 25.55 | 22.23 |
| 3B Blackbio Dx Ltd. | 3BBLACKBIO | 1,138.88 | 21.76 | 4.31 | 19.41 | 26.03 |
| LAXMI DENTAL LIMITED | LAXMIDENTL | 1,086.83 | 34.69 | 4.24 | 21.4 | 24.97 |
AVIENCE BIOMEDICALS LTD (AVIENCE-SM) has a P/E ratio of 20.47x compared with the displayed peer median of 34.69x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 49.9% compares with a peer median of 19.41% across the companies shown in the table. ROCE stood at 34.16% versus the displayed peer median of 22.23%, providing a capital-efficiency comparison. AVIENCE BIOMEDICALS LTD (AVIENCE-SM) has a market capitalisation of Rs 187.81 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching AVIENCE BIOMEDICALS LTD
- The stock rose 9.89% today and closed at Rs 359 after ending the previous session at Rs 326.7.
- Day range was Rs 321 to Rs 359.35, with turnover of Rs 3.58 cr.
- Market capitalisation stands at Rs 187.81 cr, and the company is in Healthcare, Medical Equipment/Supplies/Accessories.
- P/E is 20.47, P/B is 7.4, EPS is 15.96 and book value is Rs 44.18.
- ROE of 49.9 and ROCE of 34.16 are above the benchmark medians in the same industry.
About AVIENCE BIOMEDICALS LTD
AVIENCE BIOMEDICALS LTD operates in the Healthcare sector and the Medical Equipment/Supplies/Accessories industry. The supplied data places it in a peer set that includes other listed healthcare equipment and supplies companies, which helps readers understand the company’s business context even when a detailed product mix is not supplied. For AVIENCE BIOMEDICALS LTD Share Price readers, the company’s market position is best understood through its valuation, profitability and industry comparison rather than through broad labels.
The stock’s current market capitalisation of Rs 187.81 cr, EPS of 15.96, book value of Rs 44.18, ROE of 49.9 and ROCE of 34.16 indicate a financially measurable profile that can be tracked over time on Univest. In AVIENCE BIOMEDICALS LTD Company News and AVIENCE BIOMEDICALS LTD Stock News coverage, this kind of company overview helps connect the day’s price rise with the broader healthcare market backdrop. It also gives readers a cleaner starting point for follow-up analysis on the stock’s share price and fundamentals.
Track AVIENCE BIOMEDICALS LTD Share Price on Univest
Use AVIENCE BIOMEDICALS LTD (AVIENCE-SM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is AVIENCE BIOMEDICALS LTD Share Price rising today?
Ans. The supplied data confirms a 9.89% rise to Rs 359, but it does not establish a company-specific catalyst. Readers should treat the move as verified price action and review valuation, sector context and turnover on Univest.
What is AVIENCE BIOMEDICALS LTD Share Price today?
Ans. AVIENCE BIOMEDICALS LTD Share Price today is Rs 359. That is Rs 32.3 above the previous close of Rs 326.7 and reflects a same-day gain of 9.89% in the current session.
What is the market capitalisation of AVIENCE BIOMEDICALS LTD?
Ans. The market capitalisation is Rs 187.81 cr. Within the same-industry benchmark set, that sits slightly above the median market cap of Rs 183.31 cr and well below the average distorted by larger peers.
What do the valuation ratios show for AVIENCE BIOMEDICALS LTD?
Ans. The company’s P/E is 20.47 and P/B is 7.4. In the same-industry benchmark, the P/E is below the median while the P/B is above both the median and average. The company trades at a P/E ratio of 20.47x.
How strong are the profitability metrics for AVIENCE BIOMEDICALS LTD?
Ans. ROE stands at 49.9 and ROCE at 34.16, both above the benchmark medians for the same industry. EPS is 15.96, which gives additional context to earnings per share. ROE stands at 49.9%.
How does AVIENCE BIOMEDICALS LTD compare with peers?
Ans. The company’s P/E is lower than several listed peers, while its ROE and ROCE are higher than the peer figures supplied. Its market capitalisation is also much smaller than the largest healthcare names in the set.
What is the book value and dividend yield of AVIENCE BIOMEDICALS LTD?
Ans. Book value per share is Rs 44.18, which shows the accounting net worth behind each share. Dividend yield is 0 in the supplied data, so no dividend yield is reflected for this update.
